Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azelastine 0.15% Nasal Spray in Allergic Rhinitis
NCT06126952Phase 2Completed
- Sponsor
- Meda
- Start
- Oct 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azelastine in seasonal allergic rhinitis (SAR), sponsored by Meda. Started Oct 2023; status: completed.
02
Drugs
azelastine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT06126952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06126952.